// App-Quantinova.ai

4318 : Reversal of BRCA-1 CpG hyperthylation by genistein and (-)-epigallocatechin-3-gallate in human breast cancer cells with activated AhR

Researchers

Presenter

  • Ornella I. Selmin

Principal Investigators

  • Andreas J. Papoutsis

  • Donato F. Romagnolo

Medical Centers

  • University of Arizona Cancer Center, Tucson, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Epigallocatechin gallate

Drug/Treatment

  • EGCG

  • Alora

  • Genistein

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved